Search Results
Aug 21, 2025, 09:00 ET Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities
Aug. 21, 2025 /PRNewswire/ -- With classrooms once again filled and respiratory virus season beginning, QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, is sharing timely public health insights from Dr. Jonathan Temte, Professor
More news about: QuidelOrtho Corporation
Aug 19, 2025, 16:05 ET QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development
DIEGO, Aug. 19, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, welcomes Erich Wolff as Executive Vice President,
More news about: QuidelOrtho Corporation
Aug 13, 2025, 15:00 ET QuidelOrtho Launches Certified Analyzer Program
quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X. About QuidelOrtho Corporation QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for
More news about: QuidelOrtho Corporation
Aug 05, 2025, 16:10 ET QuidelOrtho Reports Second Quarter 2025 Financial Results
DIEGO, Aug. 5, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs
More news about: QuidelOrtho Corporation
Jul 29, 2025, 17:00 ET QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™
service trends and manufacturer ratings in laboratory diagnostics. About QuidelOrtho Corporation QuidelOrtho Corporation (Nasdaq: QDEL) is a global provider of innovative diagnostic testing solutions. From infectious diseases to cardiac biomarkers to women's health, QuidelOrtho transforms
More news about: QuidelOrtho Corporation
Jul 24, 2025, 09:00 ET Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast
www.quidelortho.com/sciencebytes. About QuidelOrtho CorporationQuidelOrtho Corporation (Nasdaq: QDEL) is a global provider of innovative diagnostic testing solutions. From infectious diseases to cardiac biomarkers to women's health, QuidelOrtho transforms
More news about: QuidelOrtho Corporation
Jul 22, 2025, 16:30 ET QuidelOrtho to Report Second Quarter 2025 Financial Results
DIEGO, July 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs
More news about: QuidelOrtho Corporation
Jul 17, 2025, 07:00 ET Real Labs, Actual Decisions With Actionable Six Sigma Metrics
lab performance? In a featured session at the Association for Diagnostics & Laboratory Medicine (ADLM) meeting, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and a panel of experts will share how QuidelOrtho's Six Sigma tools and real lab data can drive quality outcomes.
More news about: QuidelOrtho Corporation
Jul 14, 2025, 07:00 ET QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS™ SYSTEMS AS A MICROTIP™ PARTNERSHIP ASSAY (MPA)
DIEGO, July 14, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's VITROS
More news about: QuidelOrtho Corporation
Jul 07, 2025, 07:00 ET QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs
DIEGO, July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs
More news about: QuidelOrtho Corporation
Jun 03, 2025, 16:10 ET QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics
SAN DIEGO, June 3, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs,
More news about: QuidelOrtho Corporation